INTERNATIONAL PATENT: BIONTECH SE FILES APPLICATION FOR "ANTIBODY-DRUG CONJUGATES HAVING A TAILOR-MADE DRUG-TO-ANTIBODY RATIO"

GENEVA, May 12 -- BIONTECH SE (An der Goldgrube 1255131 Mainz) filed a patent application (PCT/EP2024/080607) for "ANTIBODY-DRUG CONJUGATES HAVING A TAILOR-MADE DRUG-TO-ANTIBODY RATIO" on Oct 29, 2024. With publication no. WO/2025/093562, the details related to the patent application was published on May 08, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BOGEN, Jan Patrick (An der Goldgrube 1255131 Mainz), WUSTEHUBE-LAUSCH, Joycelyn (An der Goldgrube 1255131 Mainz), SCHMOLDT, Hans-Ulrich (An der Goldgrube 1255131 Mainz)

Abstract: The present invention provides an antibody-drug conjugate ...